Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial
| Autor: | Mesa, Ruben A, Vannucchi, Alessandro M, Mead, Adam, Egyed, Miklos, Szoke, Anita, Suvorov, Aleksandr, Jakucs, Janos, Perkins, Andrew, Prasad, Ritam, Mayer, Jiri, Demeter, Judit, Ganly, Peter, Singer, Jack W, Zhou, Huafeng, Dean, James P, te Boekhorst, Peter A, Nangalia, Jyoti, Kiladjian, Jean-Jacques, Harrison, Claire N |
|---|---|
| Zdroj: | In The Lancet Haematology May 2017 4(5):e225-e236 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|